pic from 3Neus @ Flickr
Well it seems the answer is Yes.
The Adult Allergy Unit, Department of Chest Diseases, Hacettepe University School of Medicine, Ankara, Turkey in their abstract stated:
To the best of our knowledge, this is the first report on this subject in the literature.
And I bet it is.
This study was in those with seasonal rhinitis. It appears the higher the nasal hair density the less you were likely to have asthma. The rate of asthma was 44.7, 26.2 and 16.7% in the few, moderate and many (hairy nostril) groups.
I wonder who counted the hairs to determine what grouping people fell into.
So grow your hair in your nostrils to keep your airways good people.
I love this research stuff.
Int Arch Allergy Immunol. 2011 Mar 30;156(1):75-80.
Inhaled corticosteroids (ICS) are first-line therapy for asthma and are also commonly used in the treatment of chronic obstructive pulmonary disease (COPD), in particular for those patients with moderate–severe disease and frequent exacerbations. They are preferred to oral corticosteroids because of a lower risk of systemic adverse effects, although high doses of ICS have been reported to be associated with adrenal suppression, glaucoma, osteoporosis, cataracts, pneumonia, bruising and decreased growth in children.
Oral corticosteroids increase the risk of diabetes mellitus and worsen glucose control in patients already diagnosed with the disease. Case reports have linked high doses of ICS with loss of glucose control, but a randomised controlled trial in patients with mild-moderate COPD (n= 1116) did not find an increased risk of diabetes associated with ICS use. The small number of subjects in this trial is a major limitation.
Download the PDF below to continue reading.
Download (PDF, 13KB)
The 2009 RGH E-Bulletins are archived here.
If you like this post and what else you see on the blog please subscribe by RSS feed (the orange button) or by email. Visit my subscription page.
A joint initiative of the Patient Services Section and the Drug and Therapeutics Information Service of the Pharmacy Department, Repatriation General Hospital, Daw Park, South Australia. The RGH Pharmacy E-Bulletin is distributed in electronic format on a weekly basis, and aims to present concise, factual information on issues of current interest in therapeutics, drug safety and cost-effective use of medications.
Editor: Assoc. Prof. Chris Alderman, University of South Australia – Director of Pharmacy, RGH © Pharmacy Department, Repatriation General Hospital, Daw Park, South Australia 5041.